Our team has extensive expertise in chronic disease, oncology, specialized medicine, vaccines and infectious diseases, cell and genes therapies.
Driving depth in insights, solutions and engagement.
Let’s discuss our areas of expertise.
Combined expertise in understanding the patient experience, multi-disciplinary healthcare team working, poly-pharmacy and co-morbidities all underpinned with scientific rigor and expertise:
Experience and passion working in a fast-moving space – new targets, MOAs, and accelerated clinical development:
Vast experience in rare diseases, orphan drugs and gene therapies including working with small, innovative pharma and biotech:
VidERA: our custom-built vaccines and infective diseases offering combine our broad expertise across a plethora of infectious diseases, anti-infectives and vaccine solutions:
Cell and gene therapies are disrupting medicine at every level!
For patients, this could mean a long-awaited treatment or even cure.
However, bringing such a therapy to market is a journey like no other, with rapidly changing expectations and many other hidden challenges.
With our GenERA purpose-built cell and gene therapy offering, we are pioneers in this area with 300 years cumulative cell and gene therapy experience, and to date we have supported 137 therapies, across 58 technology platforms, through many key stages of the product lifecycle:
We stand at the forefront of innovation in medical affairs and medical education. We combine technology-forward solutions with our over 20 years long heritage in medical affairs and education to accelerate outcomes. Whether you are already embracing omnichannel or are actually not totally sure what it means, we can help!
